Page last updated: 2024-12-05

4-(trifluoromethyl)benzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(trifluoromethyl)benzoic acid, also known as p-trifluoromethylbenzoic acid, is an organic compound with the formula C8H5F3O2. It is a white crystalline solid that is sparingly soluble in water but soluble in organic solvents. The compound is commonly synthesized through the oxidation of 4-trifluoromethyltoluene. 4-(trifluoromethyl)benzoic acid exhibits a range of biological activities. It has been reported to possess anti-inflammatory and analgesic properties. Its derivatives have been investigated for their potential as herbicides, fungicides, and pharmaceuticals. The trifluoromethyl group imparts unique properties to the molecule, including increased lipophilicity and metabolic stability. These characteristics make it a valuable building block for the development of new drugs and other chemical entities. The compound is a subject of ongoing research due to its potential applications in various fields, including medicine, agriculture, and materials science.'

4-trifluoromethylbenzoic acid : A benzoic acid carrying a 4-trifluoromethyl substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9966
CHEMBL ID443234
CHEBI ID60696
SCHEMBL ID78879
MeSH IDM0091415

Synonyms (55)

Synonym
nsc88327
benzoic acid, 4-(trifluoromethyl)-
nsc-88327
4-(trifluoromethyl)benzoic acid
455-24-3
4-trifluoromethyl-benzoic acid
CHEMBL443234
EN300-17345
.alpha.,.alpha.,.alpha.-trifluoro-p-toluic acid
4-trifluoromethylbenzoic acid
ENAMINE_005626
NCIOPEN2_001327
p-carboxybenzotrifluoride
inchi=1/c8h5f3o2/c9-8(10,11)6-3-1-5(2-4-6)7(12)13/h1-4h,(h,12,13
4-(trifluoromethyl)benzoic acid, 98%
AC-2487
AKOS000118809
HMS1409P16
p-trifluoroformylbenzoic acid
CHEBI:60696 ,
p-trifluoromethylbenzoic acid
alpha,alpha,alpha-trifluoro-p-toluic acid
T1145
A20140
STL169371
4-trifluoromethyl benzoic acid
nsc 88327
unii-ka05x8s21z
einecs 207-242-8
para-(trifluoromethyl)benzoic acid
ka05x8s21z ,
BP-11456
FT-0619542
AM20060101
AO-801/41077414
SCHEMBL78879
DTXSID0060018
3ae ,
paratrifluoromethylbenzoic acid
W-106130
BS-4038
mfcd00002562
4-(trifluoromethyl)benzoicacid
SY001624
CS-W015914
F0001-1231
Q27128434
p-(trifluoromethyl)benzoic acid
SB13067
tecovirimat metabolite (tfmba)
tfmba
xaoxyzsqspcpoq-uhfffaoysa-n
D70992
HY-W015198
Z56922105
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
benzoic acidsAny aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group.
(trifluoromethyl)benzenesAn organofluorine compound that is (trifluoromethyl)benzene and derivatives arising from substitution of one or more of the phenyl hydrogens.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID226477Hammett constant was determined1993Journal of medicinal chemistry, Oct-01, Volume: 36, Issue:20
QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.
AID1657806Efflux ratio of permeability in human Caco2 cells measured up to 2 hrs by LC-MS/MS analysis or scintillation counting method2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Phosphine Oxides from a Medicinal Chemist's Perspective: Physicochemical and
AID1657797Acid dissociation constant, pKa of the compound by UV absorption spectra analysis or potentiometric titration technique2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Phosphine Oxides from a Medicinal Chemist's Perspective: Physicochemical and
AID1657803Aqueous solubility of the compound in pH 6.8 buffer incubated for 24 hrs under shaking condition by UV-HPLC analysis2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Phosphine Oxides from a Medicinal Chemist's Perspective: Physicochemical and
AID1657804Equilibrium thermodynamic aqueous solubility of the compound in pH 6.8 buffer incubated for 24 hrs by UV-spectroscopy based shake flask method2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Phosphine Oxides from a Medicinal Chemist's Perspective: Physicochemical and
AID28731Partition coefficient (logD2.0)1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1657805Permeability across apical to basolateral side in human Caco2 cells measured up to 2 hrs by LC-MS/MS analysis or scintillation counting method2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Phosphine Oxides from a Medicinal Chemist's Perspective: Physicochemical and
AID226478Hammett constant was evaluated1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition.
AID1657801Half life in human liver microsomes at 1 uM incubated prior to NADPH addition by LC-MS/MS analysis2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Phosphine Oxides from a Medicinal Chemist's Perspective: Physicochemical and
AID1657802Stability in human liver microsomes at 1 uM incubated prior to NADPH addition by LC-MS/MS analysis relative to hepatic blood flow2020Journal of medicinal chemistry, 07-09, Volume: 63, Issue:13
Phosphine Oxides from a Medicinal Chemist's Perspective: Physicochemical and
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (15.38)18.7374
1990's4 (30.77)18.2507
2000's1 (7.69)29.6817
2010's5 (38.46)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.62 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index34.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]